M
$ Value
$0
Shares
3,278
Price
$0
Filed
Feb 10
Insider
Name
Keeney Adam
Title
Head of Corporate Development
CIK
0001973607
Roles
Officer
Transaction Details
Transaction Date
2026-02-06
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,875
Footnotes
The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. | The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
Filing Info
Keeney Adam's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-13 | BIIB | A | $0 |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $118K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $200K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | M | $0 |
| 2025-05-01 | BIIB | M | $0 |
| 2025-05-01 | BIIB | F | $55K |
| 2025-05-01 | BIIB | M | $0 |
Other Insiders at BIIB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Murphy Nicole
Head of Pharm Ops and Tech
|
$585 | — | 2026-02-13 |
|
ALEXANDER SUSAN H
EVP Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gregory Ginger
EVP, Human Resources
|
— | — | 2026-02-13 |
|
Kramer Robin
Chief Financial Officer
|
— | — | 2026-02-13 |
|
Singhal Priya
Head of Development
|
— | $666K | 2026-02-13 |
|
Viehbacher Christopher
President and CEO
|
— | — | 2026-02-13 |
|
Izzar Rachid
Head of Global Product Strat.
|
— | — | 2026-02-13 |
|
Keeney Adam
Head of Corporate Development
|
— | — | 2026-02-13 |
|
Grogan Jane
Head of Research
|
— | — | 2026-02-13 |
|
Godbout Sean
Chief Accounting Officer
|
— | — | 2026-04-01 |